Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-027010
Filing Date
2014-04-10
Accepted
2014-04-10 17:16:30
Documents
2
Period of Report
2014-04-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 31095
2 POA DOCUMENT poa.txt EX-24.3_518105 3973
  Complete submission text file 0001209191-14-027010.txt   36556
Mailing Address C/O MOMENTA PHARMACEUTICALS, INC. 43 MOULTON STREET CAMBRIDGE MA 02138
Business Address
Crane Alan L (Reporting) CIK: 0001294361 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36395 | Film No.: 14758040

Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Issuer) CIK: 0001401914 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations